IP Library Granted Patent US 11,261,471
Granted Patent B2
US 11,261,471 · App. 16/414,465 · Granted Mar 1, 2022

Methods and compositions for making vault particles in yeast

Inventors: Leonard H. Rome (Tarzana, CA); Shaily Mahendra (Santa Monica, CA); Meng Wang (Los Angeles, CA); Valerie A. Kickhoefer (Sherman Oaks, CA); Oliver Karl Foellmer (Santa Monica, CA)
Assignees: The Regents of the University of California; Vault Pharma Inc.
C12P21/02A61J3/00A61K47/00A61K47/42B82Y5/00C07K14/47C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,261,471
App. No.
16/414,465
Granted
Mar 1, 2022
Kind
B2
Abstract

Disclosed herein are methods and compositions for making vault particles in yeast hosts and yeast vaults produced therefrom.

Claims (21)

1. A yeast host cell, which comprises a nucleic acid sequence that encodes a major vault protein (MVP) sequence having 95-100% sequence identity to SEQ ID NO: 2, wherein said nucleic acid sequence comprises at least 95% sequence identity to SEQ ID NO: 1.

2. The yeast host cell according to claim 1 , wherein the yeast host cell contains multiple copies of the nucleic acid sequence.

3. The yeast host cell according to claim 1 , wherein the nucleic acid sequence is under the control of a promoter such as a constitutive promoter, an inducible promoter, or a yeast promoter.

4. The yeast host cell according to claim 1 , wherein the yeast host cell has been recombinantly modified to express one or more passenger peptides.

5. The yeast host cell according to claim 1 , wherein the yeast host cell is a microorganism belonging to the family Saccharomycetaceae.

6. A method of making a major vault protein (MVP) in a yeast host, which comprises culturing the yeast host cell according to claim 1 under conditions suitable for expression of the major vault protein.

7. A method of making a vault particle in a yeast host, which comprises culturing the yeast host cell according to claim 1 under conditions suitable for formation of the vault particle.

8. A method of producing a commercial-scale amount of vault particles, which comprises culturing the yeast host cell according to claim 1 in a cell culture medium to obtain a host cell culture that is at or near a stationary growth phase.

9. The method according to claim 7 , and further comprising extracting the vault particle from the yeast host cell or cells of the host cell culture.

10. The method according to claim 7 , and further comprising packaging one or more passenger molecules on or in the vault particle by (a) covalently linking the one or more passenger molecules to the N-terminus and/or C-terminus of the major vault protein, (b) mINT fusion packaging, and/or (c) passive packaging.

11. The method according to claim 7 , and further comprising packaging one or more mINT passenger molecules within the cavity of the vault particle.

12. A composition comprising one or more yeast host cells according to claim 1 , one or more major vault proteins made by culturing the one or more yeast host cells, and/or one or more vault particles expressed by the one or more yeast host cells.

13. The method according to claim 8 , and further comprising extracting the vault particle from the yeast host cell or cells of the host cell culture.

14. The method according to claim 8 , and further comprising packaging one or more passenger molecules on or in the vault particle by (a) covalently linking the one or more passenger molecules to the N-terminus and/or C-terminus of the major vault protein, (b) mINT fusion packaging, and/or (c) passive packaging.

15. The yeast host cell according to claim 1 , wherein the yeast host cell is a microorganism belonging to the genus Pichia.

16. The yeast host cell according to claim 1 , wherein the amino acid sequence of the major vault protein is SEQ ID NO: 2.

17. A yeast host cell comprising a nucleic acid sequence comprising SEQ ID NO: 1.

18. The yeast host cell according to claim 1 , wherein said nucleic acid comprises at least 96% sequence identity to SEQ ID NO: 1.

19. The yeast host cell according to claim 1 , wherein said nucleic acid comprises at least 97% sequence identity to SEQ ID NO: 1.

20. The yeast host cell according to claim 1 , wherein said nucleic acid comprises at least 98% sequence identity to SEQ ID NO: 1.

21. The yeast host cell according to claim 1 , wherein said nucleic acid comprises at least 99% sequence identity to SEQ ID NO: 1.

Assignments (3)
CONFIRMATORY LICENSE Recorded Sep 13, 2019
From: UNIVERSITY OF CALIFORNIA, LOS ANGELES
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 050376/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2019
From: ROME, LEONARD H.; MAHENDRA, SHAILY; WANG, MENG; KICKHOEFER, VALERIE ANN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 049382/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2019
From: FOELLMER, OLIVER KARL
To: VAULT PHARMA, INC.
Reel/Frame 049382/0130 →
Continuity (2)
Provisional Application 62673240 · May 18, 2018
Related Publication 20190352689A1 · Nov 21, 2019